Cardiovascular disease and diabetes mellitus in Norway during 1994-2009 CVDNOR – a nationwide research project
AbstractBackground: Although having a long tradition in cardiovascular epidemiologic research, nationwide data on cardiovascular disease (CVD) incidence and morbidity has not been available in Norway. Objectives: The main objectives of The Cardiovascular Disease in Norway (CVDNOR) project are 1) to study trends in CVD incidence, prevalence, survival and mortality and 2) providing CVD endpoints for national and regional health surveys and clinical studies. Methods: CVDNOR includes information from all hospital stays with a CVD, including congenital heart defects, or diabetes mellitus (DM) primary or secondary diagnosis code during 1994-2009. Information was retrieved from the electronic Patient Administrative Systems (PAS) from all Norwegian somatic hospitals. Data include age, gender, municipality of residence, hospitalization and discharge dates, main and secondary diagnoses and CVD-related procedure codes. All deaths due to CVD or DM are also included, as well as sociodemographic information and linkage to Cohort Norway (CONOR). In sub-projects we have also linked CVDNOR to the Medical Birth Registry of Norway and to the Cancer Registry. Results: During 1994-2009, 1.3 million patients (4.3 mill hospitalizations) had a CVD diagnosis or procedure code, or DM. Of these, 470895 (35.8%) died during 1994-2010. In addition, 68523 men and women died from CVD without being hospitalized for CVD or DM during the same period. Among 173243 CONOR participants, 9075 (5%) died after participating in the health survey and through 2010. A total of 44118 (25.5%) CONOR participants had a CVD and 7575 (4.4%) had a DM related hospitalization after participating in CONOR, through 2009. In CVDNOR, 53039 (4%) had congenital heart defect codes. Conclusions: CVDNOR will be a valuable source of information supporting future epidemiologic research, with important implications for prevention and treatment strategies.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).